Ana Pedrero Gil/LinkedIn
Jul 24, 2026, 04:53
Ana Pedrero Gil: The Future of Blood-Derived Therapies
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn about a recent article by Kerstin Wendland et al., published in Transfusion Medicine and Hemotherapy, adding:
“Donated blood is no longer used only as standard transfusion components but is increasingly being developed into new types of therapies.
This review explains recent progress in turning plasma, red blood cells (RBCs), platelets, donor stem cells, and cord blood into more advanced medical products.”
Title: From Donation to Innovation: New Blood-Derived Products
Authors: Kerstin Wendland, Kathleen Selleng, Konstanze Aurich
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?